Akt cross talks with MAPK and NF-κB inducing overexpression of P-gp and MDR in cancer cells with EMT/CSC phenotypes[128,150], as well as activating programmed death-ligand 1 expression which leads to immunosuppression[147]. Here, AKT1 is linked to cancer.